8-KThe WireStrategic
Material Agreement · New Debt / Obligation
Filed Apr 17, 2026 · 2mo ago · Accession 0001193125-26-161800
Plain English
Revolution Medicines, Inc. entered into a material definitive agreement to issue $500,000,000 aggregate principal amount of its 0.50% Convertible Senior Notes due 2033. This also created a direct financial obligation for the company.
Filing details
- Company
- Revolution Medicines, Inc.
- Ticker
- RVMD
- CIK
- 1628171
- Form type
- 8-K
- Filing date
- Apr 17, 2026
- Report date
- Apr 14, 2026
- Document
- d19920d8k.htm
- Size
- 1.6 MB